McMaster University Department of Medicine
A

Immune Checkpoint Inhibitor Toxicities in the ICU: A Review

By McMaster University Department of Medicine FEATURING Arman Zereshkian, Rachel Gerber, Laura Spatafora
By McMaster University Department of Medicine FEATURING Arman Zereshkian, Rachel Gerber, Laura Spatafora
116 views
April 11, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

21:17
Janssen Oncology

The Man Cave

Feat. J. Hamilton, M. Fabrizio, M. Taha

Related Content

AUTOPLAY
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
10:22
Houston Methodist Hospital

mRNA Vaccine in Treatment of Pancreatic Cancer

Feat. J. Gonzalez
13:37
SIR 2023 Conference Coverage

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

Feat. N. Kothary
15:58
Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers
53:42
PleXus Communications

Managing Women's Health in Menopause: Evolving Approaches for t…

Feat. J. Simon, T. Iyer, A. Fiffick, M. Minkin
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

11:43
University of Colorado Department of Medicine

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

Feat. L. Kondapalli
07:10
Viktor Grünwald

Updated Results From the CLEAR Trial: Outcomes of the Combination of…

16:19
OncoAlert

Year in Review: RCC Practice Changing and Practice Informing Trials …

Feat. T. Choueiri
18:46
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson
09:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab f…

Feat. B. McGregor
21:55
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Overcoming Barriers to Extend Survival: Promising Results of Clinica…

Feat. S. Brem
15:17
ASCO GU 2023 Conference Coverage

ASCO GU 2023 Systemic Therapy for Recurrent Metastatic RCC: Beyond S…

Feat. T. Zhang
15:44
Matthew Campbell

How to Select Frontline Therapy for Metastatic Clear Cell RCC

09:35
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "State-of-the-Art in Adjuvant Treatment of …

Feat. G. de Velasco
23:16
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Optimizing Therapy Selection for Patients…

Feat. B. McGregor
23:02
Cleveland Clinic Taussig Cancer Institute

Pulmonary Complications of Checkpoint Inhibitor Therapy

Feat. M. Smith
09:54
Insights from 2024 ASCO® GU Annual Meeting

The Impact of Immunotherapy-Based Regimens in Primary Renal Tumors

Feat. R. McKay